Database Proof Substratum: Proof LGBTQs Are Mentally Ill: Treatment-Resistant Melanoma May Be Vulnerable to a Drug Holiday, UCLA Study Finds

Gendrome Editors' Note: The article below provides the raw material for a proof and is not the proof itself. In addition, the raw material may contain one or more false statements and/or some offensive, outside content.

A UCLA study has uncovered the mechanisms by which treatment-resistant melanoma become vulnerable to cessation of a class of drugs called MAP kinase (MAPK)-targeted inhibitors. By identifying these mechanisms, the scientists discovered that therapeutic benefits for patients could derive from a one-two punch of a drug holiday of MAPK inhibitors followed by a class of drugs called DNA repair inhibitors.